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clinical AF” or “had atrial high rate events AHRE”). In MOST trial, AHRE
were seen in almost 50% of patients treated for sinus node dysfunctionand
were associated with an increased risk of stroke (1.69% per year if CHADS
score>2) in ASSERT study. Nevertheless currently there are no antithrombotic
recommendations for these patients. We tried to describe the different thera-
peutic alternatives in usual practice.
Materials and methods: We started a prospective registry of patients with
silent AF detected in DDD or CRT PMK/ICD of all constructors. Inclusion
criteria were: age > 18 y, AHRE diagnosed by device algorithms and > 6 min-
utes duration, confirmation by atrial endocavitary electrogram. We excluded
patients with a previous history of “clinical AF”or valvular AF. The anti-
thrombotic strategy was decided by the referent physician.
Results: From November 2013 to May 2014, 43 patients were included.
The median age was 77 years old. 26 patients (60%) had a DDD PMK (10 for
sinus node dysfunction (23%), 15 for AV block (35%), 1 for obstructive
CMP), 10 patients (23%) a DDD ICD (6 (14%) for primary prevention and 4
(9%) for secondary prevention) and 7 patients a CRT-D (16%). The median
CHADS2 score was 2, the median CHADS2VASCscore was 4 (mean respec-
tively 2.36 and 3.56): 5 patients had a history of embolic event (11%). Only
28 patients (65%) were on anticoagulation therapy: 15 (35%) antivitamin K
and 13 (30%) new oral anticoagulants. 10 patients (23%) received aspirin and
5 patients the association aspirin/clopidogrel (11%). 2 patients did not receive
any antithrombotic treatment. There were no difference in CHADS and
CHADSVASC scores between patients treated or not with anticoagulants
(respectively p=0.21 and p =0.57)
Conclusion: Most of patients in this study received an anticoagulation
therapy as a stroke prevention strategy.
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Introduction: Preserved intrinsic conduction in paced sinus node disease
(SND) patients seems to be associated with a better outcome when compared with
apical right ventricular (RV) DDD pacing.The prospective, multicenter, random-
ized OPTIMIST study was designed to compare RV lead positioning in the
septum to preserved intrinsic conduction in chronically paced SND patients.
Methods: SND patients with a class I indication were implanted with a
DDD pacemaker (St. Jude medical), the RV lead being located in the mid-
septum. The algorithm VIP™ (Ventricular Intrinsic Preference) was pro-
grammed « on » in all patients at hospital discharge. After a 6 weeks observa-
tional period, patients with a ventricular pacing percentage inferior to 10%
were randomized in 2 parallel groups: VIP « on » (preserved natural conduc-
tion – group 1) or « off » with AV delay optimization (RV pacing – group 2).
Patients were followed every 6 months with echocardiography through
18 months. The primary endpoint was the left ventricular end-systolic diam-
eter (LVESD) (Corelab analysis), with a non inferiority hypothesis.
Results: 216 patients mean age 76.07±9.45 were included and 167 ran-
domized. The baseline characteristics were comparable in group 1 and 2
including left ventricular ejection fraction, LVEF (62.4±12.6 vs 64.4±8.7%),
LVESD (32.7±8.5 vs 32.5±9.3mm) and 6 weeks RV pacing percentage
(1.81±1.92 vs 2.15±2.07%). At the end of FU, as expected the percentage of
RV pacing was significantly higher in group 2 (78.9±31.6 vs 7.9±17.4%). The
LVEF was 62.3±10.1% in group 1 and 60.9±10.9% in group 2 (NS) and the
LVESD was 31.9±7.23mm in group 1 and 31.26±7.21mm in group 2 (NS).
The non-inferiority hypothesis was validated (p=2.572e-06 for a delta =
4.785). AF burden was not different between the 2 groups.
Conclusion: When implanting the RV lead in the midseptum, DDD pacing
with high percentage of RV capture was not associated with LV echocardio-
graphic deterioration as compared to preserved intrinsic conduction pacing mode. 
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Background: Resting heart rate (RHR) is known as a cardiovascular risk
factor (RF), correlated with hypertension, cardiac failure and coronary artery
disease. The aim of this study was to assess the risk of all-cause mortality in
a general population in a prediction algorithm including RHR as an indepen-
dent parameter.
Methods: Our study population consisted in patients, both women and
men, who had consulted from 1995 to 2011 to the Department of Preventive
Cardiology (DPC) in a Southwestern French University Hospital. We
excluded patients whose age was less than 30 years old and all patients with
established history of ischemic heart disease. An algorithm for prediction of
risk of mortality in primary prevention was built using Kaplan-Meier statistic
and a Cox proportional hazards model.
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